Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
The present study was undertaken to develop sustained release (SR) matrix tablets of losartan potassium, an angiotensin-II antagonist for the treatment of hypertension. The tablets were prepared by direct compression method, along with Kollidon SR as release retardant polymer. The amount of losartan...
Saved in:
Main Authors: | Shahid Sarwar (Author), Mohammad Salim Hossain (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2012-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
by: D D Vohra, et al.
Published: (2012) -
Preparation, optimization and characterization of multiple unit microspheres containing kollidone SR
by: Marvin I Patel, et al.
Published: (2012) -
Development of lipid micromatrices based sustained release tablets of glipizide: suitability of stearic acid as release retardant
by: Deepak Singh, et al.
Published: (2016) -
Formulation and Evaluation of Sustained Release Matrix Tablets of Aceclofenac
by: Priyanka Singh, et al.
Published: (2021) -
Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
by: Qiuhua Luo, et al.
Published: (2022)